Early proof-of-concept studies have shown significant protection from liver necrosis and reductions in key liver injury markers.
Founders
Felix Alexander Baier
Company Description
CALDRE is targeting the gap in the market with an innovative drug, ClagalsiR, which increases bile flow and mitigates liver damage in cholestatic liver diseases.